EXCEL Sub-Analysis: Angioplasty vs. Surgery in Chronic Renal Insufficiency

EXCEL patients with chronic kidney disease and left main coronary artery disease have higher rates of acute renal failure and other events compared with the general population. However, acute renal failure was less frequent with angioplasty than with surgery, while other events such as death, stroke, or infarction at 3 years were similar for both revascularization strategies and in patients with or without chronic kidney disease.

Sub análisis del EXCEL: angioplastia vs cirugía en insuficiencia renal crónicaThis study investigates the comparative effectiveness of angioplasty vs. surgery in patients with left main coronary artery disease and low or intermediate anatomical complexity according to baseline renal function values from the EXCEL (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial.

 

Chronic kidney disease was defined as an estimated glomerular filtration rate <60 ml/min/1.73 m² using the CKD Epidemiology Collaboration equation. Acute renal failure or new acute flare of chronic renal failure was defined as a serum creatinine increase ≥5.0 mg/dl from baseline or a new requirement for dialysis. The primary endpoint was a classic composite of death, infarction, and stroke at 3 years.


Read also: TCT 2018 | RADIOSOUND-HTN: Testing Different Renal Ablation Techniques and Devices.


Chronic kidney disease was diagnosed in 19.3% of the global study population (361 of 1869 patients). Patients with chronic kidney disease had more events at 3 years compared with patients with regular kidney function (20.8% vs. 13.5%; hazard ratio [HR]: 1.60; 95% confidence interval [CI]: 1.22 to 2.09; p = 0.0005).

 

Acute renal failure within 30 days from the procedure obviously occurred more commonly in patients with baseline chronic disease (5.0% vs. 0.8%; p < 0.0001), and it was strongly associated with death, infarction, or stroke at 3 years (50.7% vs. 14.4%; HR: 4.59; 95% CI: 2.73 to 7.73; p < 0.0001). Acute renal failure was less common after revascularization with angioplasty compared with surgery in patients with regular renal function (0.3% vs. 1.3%) as well as in those with baseline chronic renal insufficiency (2.3% vs. 7.7%).


Read also: Renal Impairment: How Does It Affect Angioplasty and Surgery?


There were no significant differences in the primary endpoint rates after angioplasty or surgery in patients with baseline chronic kidney disease (23.4% vs. 18.1%) as well as in those with regular renal function (13.4% vs. 13.5%; p for interaction = 0.38).

 

Conclusion

Patients with chronic renal insufficiency who underwent revascularization for left main coronary artery disease in the EXCEL trial had increased rates of acute renal failure and other events. Acute renal failure was less common among patients who underwent angioplasty.

 

Original title: Left Main Revascularization with PCI or CABG in Patients with Chronic Kidney Disease. EXCEL Trial.

Reference: Gennaro Giustino et al.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....